Clinical Trial Update: The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of patiromer on serum potassium and gut microbiome in patients with end-stage renal disease and hyperkalemia; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Dominic Raj | Conditions: ESRD, Hyperkalemia | Phase 2 | Status: COMPLETED | Results posted: 2023-03-22